COVID-19 vaccination in Malaysia

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
COVID-19 vaccination in Malaysia
Date24 February 2021 (2021-02-24) – present
LocationMalaysia
CauseCOVID-19 pandemic in Malaysia
TargetFull immunisation of people in Malaysia against COVID-19
Organised byMinister of Health of Malaysia
Participants905,683 people have received at least one dose administered of Pfizer–BioNTech or Sinovac
(2 May 2021)
563,350 people have been fully vaccinated (both doses of Pfizer–BioNTech or Sinovac)[1]
Websitewww.vaksincovid.gov.my/en/

The COVID-19 vaccination programme in Malaysia is a vaccination campaign that is currently being implemented by the Malaysian government as an approach in curbing the spread of coronavirus disease 2019 (COVID-19) and ending the COVID-19 pandemic in Malaysia by successfully achieving the herd immunity among its citizens and non-citizens that are residing in Malaysia.[2] Khairy Jamaluddin who is also Malaysia's Science, Technology and Innovation Minister, has been appointed as the Coordinating Minister for the immunization program after being approved by the Malaysian Cabinet.[3] The COVID-19 Vaccine Supply Access Guarantee Special Committee (JKJAV) co-chaired by Malaysia's Health Minister and Science, Technology and Innovation Minister was also established to ensure the procurement of COVID-19 vaccine supply for the country can be carried out in an orderly manner. The immunization program is currently being implemented in phases from 24 February 2021 to February 2022, and Malaysia's Prime Minister Muhyiddin Yassin became the first individual in Malaysia to receive the COVID-19 vaccine when it was broadcast live nationwide.[4]

Vaccines on order[edit]

Vaccine Approval Deployment
Pfizer–BioNTech Green check.svg Yes Green check.svg Yes
Oxford–AstraZeneca Green check.svg Yes Dark Red x.svg Not yet
Sinovac Green check.svg Yes Green check.svg Yes
Cansino Pending Dark Red x.svg Not yet
Gamaleya Pending Dark Red x.svg Not yet

Vaccines in trial stage[edit]

Vaccine Type (technology) Phase I Phase II Phase III
Anhui Zhifei Subunit Green check.svg Completed Green check.svg Completed Green check.svg Completed
Chinese Academy of Medical Sciences Inactivated Green check.svg Completed Green check.svg Completed In progress

History[edit]

2020[edit]

In mid-March 2020, Malaysian Vaccines and Pharmaceuticals (MVP) Sdn Bhd reportedly pleaded for co-operation and support from the federal government, with its executive director claiming that their company faced multiple postponed meetings in an attempt to meet the health minister to request for a sample from the Institute of Medical Research (IMR) of Malaysia.[5] The IMR was set to begin testing existing local vaccines in collaboration with the MVP and University of Malaya's Tropical Infectious Diseases Research and Education Centre (TIDREC) by 25 March. The local vaccine testing will be conducted in UM's TIDREC laboratory, which is one of Malaysia's modular biosafety level 3 (BSL3) facilities previously used to study highly pathogenic agents such as MERS coronavirus and Nipah virus with the vaccines to be firstly tested on the infectious bronchitis virus (IBV), which is an avian coronavirus, as previous research shows that the IBV in poultry has high genetic similarity with the human coronavirus.[6][7]

On 6 October, the engineering company Bintai Kinden entered into a distribution and licensing agreement (DLA) with the American–based firm Generex Biotechnology Corp and its subsidiary NuGenerex Immuno-Oncology Inc to distribute their COVID-19 vaccine in Malaysia through its subsidiary Bintai Healthcare. The company will also have the first right of refusal to commercially exploit the vaccine within Australia, New Zealand and the global halal market.[8]

On 18 November, the Minister of Science, Technology and Innovation Khairy Jamaluddin signed an agreement with Chinese Science and Technology Minister Wang Zhigang for Malaysia to be given priority access to COVID-19 vaccines developed in China.[9]

On 19 December, Health Minister Dr Adham Baba confirmed that the Malaysian Government would be concluding an agreement with British pharmaceutical company AstraZeneca to purchase COVID-19 vaccines on 21 December 2020. This is the third agreement that the Malaysian Government had concluded with vaccine suppliers including COVAX and Pfizer to address the country's vaccine needs.[10]

On 22 December, the Malaysian Government signed an agreement with AstraZeneca to obtain an addition 6.4 million doses of COVID-19 vaccines, which account ten percent of the country's vaccine supply. Prime Minister Muhyiddin confirmed that Malaysia had secured 40% of its vaccine supply through joint agreements with COVAX, Pfizer, and AstraZeneca.[11]

2021[edit]

On 11 January 2021, the Health Ministry ordered an additional 12.2 million doses of the Pfizer–BioNTech COVID-19 vaccine in response to rising cases and the tightening of lockdown measures.[12]

On 26 January, the Health Ministry signed an agreement with local pharmaceutical companies Pharmaniaga Berhad and Duopharma to obtain 18.4 million doses of COVID-19 vaccines from China and Russia for distribution in Malaysia.[13]

On 27 January, Health Minister Dr. Adham Baba confirmed that launch of Malaysia's first COVID-19 vaccine trial. This vaccine trial involves the Phase 3 clinical trial of the Covid-19 vaccine developed by the Chinese Academy of Medical Sciences' Institute of Medical Biology.[14]

On 2 February, the Director-General of Health Noor Hisham Abdullah announced that Malaysia would receive its first batch of the Pfizer–BioNTech COVID-19 vaccine on 26 February 2021, which will be distributed nationwide over a period of two weeks.[15]

On 11 February, the Special Committee on Ensuring Access to Covid-19 Vaccine Supply announced that COVID-19 vaccines would be distributed freely to both Malaysians and foreigners residing in Malaysia. However, Malaysian nationals will receive priority.[16]

On 16 February, the Minister of Science, Technology and Innovation Khairy Jamaluddin confirmed that a MASKargo plane will transport the first shipment of Pfizer-BioNTech vaccines to Malaysia on 21 February.[17]

On 23 February, Coordinating Minister for National Covid-19 Immunisation Programme Khairy Jamaluddin confirmed that it would receive its second batch of 182,520 doses of Pfizer-BioNTech vaccines the following day. These will be distributed to states that have not yet received the vaccine.[18]

By 26 February, the Science, Technology and Innovation Minister Khairy Jamaluddin confirmed that a million people had registered for COVID-19 vaccines via the MySejahtera app.[19]

On 4 March 2021, the Special Committee on Ensuring Access to Covid-19 Vaccine Supply (JKJAV) confirmed that 80,336 Malaysians had received their first COVID-19 vaccine dose.[20]

On 15 March 2021, the Science, Technology and Innovation Minister Khairy Jamaluddin announced that Pfizer would be sending 1,000,350 doses of the Pfizer-BioNTech vaccines to Malaysia by the end of the month.[21] That same day, Jamaluddin confirmed that Malaysia would begin administering the CoronaVac vaccine on 18 March.[22]

On 29 March, the Science, Technology and Innovation Minister Khairy confirmed that the second phase of the national immunisation programme would begin on 19 April 2021 and target the elderly, disabled and those with comorbidities.[23]

On 1 April, Health Minister Adham Baba announced that the second phase of the National Covid-19 Immunisation Programme would start on 17 April 2021, two days ahead of the earlier scheduled date.[24]

On 9 April, Communications and Multimedia Minister Saifuddin Abdullah noted specific efforts to inform Orang Asli communities was intensifying, including through radio broadcasts.[25]

On 27 April, Health Minister Adham Baba announced that Malaysia would use the Oxford–AstraZeneca COVID-19 vaccine after health authorities approved its use following a thorough study of clinical assessment and data.[26] The following day, Malaysian health authorities removed the AstraZeneca vaccine from the country's mainstream vaccination programme due to public anxiety about its safety following reports of bloodclotting. The initial 268,600 initial doses will be redirected to Selangor and the federal territory of Kuala Lumpur.[27]

Vaccinations by state[edit]

As of 2 May 2021

State/Federal Territory Vaccinated
(at least one dose)
 Johor 82,433
 Kedah 58,539
 Kelantan 43,701
 Kuala Lumpur 90,611
 Labuan 9,151
 Malacca 31,252
 Negeri Sembilan 38,935
 Pahang 62,141
 Penang 63,688
 Perak 73,017
 Perlis 17,332
 Putrajaya 8,980
 Sabah 75,911
 Sarawak 93,353
 Selangor 120,749
 Terengganu 35,890
Total 905,683

References[edit]

  1. ^ "Dr Adham: 555,288 individuals complete two-dose COVID-19 vaccination". 2 May 2021. Retrieved 2 May 2021. CS1 maint: discouraged parameter (link)
  2. ^ PROGRAM IMUNISASI COVID-19 KEBANGSAAN (PDF). Malaysia: URUSETIA JAWATANKUASA KHAS JAMINAN AKSES BEKALAN VAKSIN COVID-19. 18 February 2021. p. 26.
  3. ^ Azman, Fareez (4 February 2021). "Khairy dilantik sebagai Menteri Penyelaras Program Imunisasi COVID-19 Kebangsaan - Muhyiddin". Astro Awani. Archived from the original on 5 February 2021. Retrieved 25 February 2021.
  4. ^ Hamid, Amir Abd (24 February 2021). "Program Imunisasi Covid-19 Kebangsaan bermula [METROTV]". MyMetro. Archived from the original on 24 February 2021. Retrieved 25 February 2021.
  5. ^ Loheswar, R. (20 March 2020). "With Malaysian-made Covid-19 vaccine a possibility, firm pleads for Putrajaya's backing". The Malay Mail. Archived from the original on 9 April 2020. Retrieved 9 April 2020.
  6. ^ "IMR begins testing to develop vaccines for Covid-19". New Straits Times. 25 March 2020. Archived from the original on 9 April 2020. Retrieved 9 April 2020.
  7. ^ Minion, RD (30 March 2020). "Institute For Medical Research Malaysia Begins Testing Local Vaccines To Treat COVID-19". RojakDaily. Archived from the original on 9 April 2020. Retrieved 9 April 2020.
  8. ^ Wong, Ee Lin (6 October 2020). "Bintai Kinden to be distributor, licensee for Covid-19 vaccine in Malaysia". The Edge. Archived from the original on 6 October 2020. Retrieved 6 October 2020.
  9. ^ Babulal, Veena (18 November 2020). "Malaysia, China ink agreement for vaccine access". New Straits Times. Archived from the original on 18 November 2020. Retrieved 19 November 2020.
  10. ^ "Dr Adham: Govt to seal vaccine purchase with AstraZeneca on Monday". Malay Mail. Bernama. 19 December 2020. Archived from the original on 19 December 2020. Retrieved 19 December 2020.
  11. ^ "M'sia inks agreement with AstraZeneca to procure 6.4 million doses of Covid-19 vaccine". The Star. 22 December 2020. Archived from the original on 22 December 2020. Retrieved 22 December 2020.
  12. ^ Kumar, P. Prem (11 January 2021). "Malaysia doubles Pfizer COVID vaccine order as it locks down anew". Nikkei Asia. Archived from the original on 11 January 2021. Retrieved 11 January 2021.
  13. ^ Choong, Jerry (26 January 2021). "Health Ministry: Malaysia secures 18.4 million doses of Russian, Chinese Covid-19 vaccines". Malay Mail. Archived from the original on 26 January 2021. Retrieved 29 January 2021.
  14. ^ "Malaysia's first Covid-19 vaccine trial officially underway". The Star. 27 January 2021. Archived from the original on 27 January 2021. Retrieved 27 January 2021.
  15. ^ "Malaysia to receive first batch of COVID-19 vaccines as country reports more than 4,000 new cases". Channel News Asia. 1 February 2021. Archived from the original on 2 February 2021. Retrieved 2 February 2021.
  16. ^ Koya, Zakiah (11 February 2021). "Covid-19: All residing in M'sia to get vaccines, including non-citizens, says Cabinet". The Star. Archived from the original on 11 February 2021. Retrieved 11 February 2021.
  17. ^ Bedi, Rashvinjeet (16 February 2021). "Khairy: First shipment of Covid-19 vaccine to be 312,390 doses". The Star. Archived from the original on 16 February 2021. Retrieved 16 February 2021.
  18. ^ "Covid-19: Khairy says Malaysia to receive additional 182,520 doses of Pfizer-BioNTech vaccine tomorrow". Malay Mail. 23 February 2021. Archived from the original on 23 February 2021. Retrieved 23 February 2021.
  19. ^ Chung, Clarissa (26 February 2021). "A million people have registered for Covid-19 vaccine via MySejahtera, says Khairy". The Star. Archived from the original on 27 February 2021. Retrieved 26 February 2021.
  20. ^ "Covid-19 vaccination: More than 80,000 people have received their first dose so far". The Star. 4 March 2021. Archived from the original on 4 March 2021. Retrieved 4 March 2021.
  21. ^ Kaos, Jr., Joseph (15 March 2021). "Covid-19: M'sia to receive 1,000,350 doses of Pfizer-BioNTech vaccine by end March, says Khairy". The Star. Archived from the original on 15 March 2021. Retrieved 15 March 2021.
  22. ^ Kanyakumari, D. (15 March 2021). "Malaysia to begin administering Sinovac's COVID-19 vaccine on Thursday". Channel News Asia. Archived from the original on 15 March 2021. Retrieved 15 March 2021.
  23. ^ Pfordten, Diyana (29 March 2021). "Covid-19: Second phase of national immunisation programme to begin April 19, says Khairy". The Star. Archived from the original on 29 March 2021. Retrieved 30 March 2021.
  24. ^ "Covid-19: Second phase of national immunisation programme brought forward to April 17". The Star. 2 April 2021. Archived from the original on 2 April 2021. Retrieved 2 April 2021.
  25. ^ "Covid-19 immunisation programme: Efforts to reach out to Orang Asli will be intensified, says minister". Malay Mail. 9 April 2021. Retrieved 9 April 2021.
  26. ^ "M'sia to start using AstraZeneca". The Star. 27 April 2021. Archived from the original on 27 April 2021. Retrieved 27 April 2021.
  27. ^ Tan, Vincent (28 April 2021). "AstraZeneca removed from Malaysia's mainstream COVID-19 immunisation programme due to public concerns: Khairy". Channel News Asia. Archived from the original on 28 April 2021. Retrieved 28 April 2021.

External links[edit]

Retrieved from "https://en.wikipedia.org/w/index.php?title=COVID-19_vaccination_in_Malaysia&oldid=1021194225"